Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza and Vineti announced a partnership in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.
read more
Friday, February 05, 2021
Moleculin Biotech has signed an agreement with Catalyst to manage its US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma that has metastasized to the lungs.
read more
Wednesday, January 13, 2016
AMRI has announced the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts.
read more
Thursday, October 01, 2020
Almac Sciences has announced the expansion of its existing suite of analytical solutions to include biologics testing.
read more
Monday, December 07, 2020
BioNTech and InstaDeep announced a collaboration aimed at applying the latest advances in AI and ML technology to develop novel immunotherapies.
read more
Alembic is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level.
read more
Cambrex announced the completion of an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale laboratory to undertake the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) ...
read more
Phastar, a global biometrics contract research organization (CRO), announced it is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily ...
read more
Schreiner MediPharm, a provider of specialty pharmaceutical labeling, has developed – in close cooperation with the Clinical Trial Supplies Unit of Sanofi in Montpellier, France – an innovative solution for blinding syringes during clinical study ...
read more
Patheon, a global provider of pharmaceutical development and manufacturing services, has reported financial results for the quarter ended January 31, 2017.
read more
Boehringer Ingelheim and Eli Lilly announced plans to expand their clinical trial program for empagliflozin in chronic heart failure with the EMPERIAL clinical trials.
read more
Orphan Therapeutics Accelerator, a non-profit biotech dedicated to advancing therapies for ultra-rare conditions, announced that Viralgen has become a Contract Development and Manufacturing Organization partner within OTXL's Orphan ClinDevNet network...
read more
Palisade Bio, Inc. announced the successful completion of the first Good Manufacturing Practice (GMP) batch of its drug substance PALI-2108, an orally administered, locally acting colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug in ...
read more
Wednesday, February 07, 2018
Biostar Pharmaceuticals announced its variable interest entity in China, Shaanxi Aoxing Pharmaceutical, has renewed its GMP certificate and Pharmaceutical Production License.
read more
Wednesday, September 12, 2018
Amneal has received FDA approval on its ANDA for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg and has immediately initiated commercialization activities.
read more